Remoxipride — a new potential antipsycho
✍
L. Farde; M. Grind; M.-I. Nilsson; S. Ogenstad; G. Sedvall
📂
Article
📅
1988
🏛
Springer
🌐
English
⚖ 460 KB
Remoxipride, a new potential antipsychotic drug, was administered over 4 days at two dose levels, 70 and 140 mg t.i.d., to eight healthy male volunteers. Pharmacokinetics, safety, tolerabillty, and effect on plasma prolactin levels were evaluated. Remoxipride exhibited essentially linear pharmacokin